Skip to main content

Advertisement

Table 1 Comparison of sham and dyslipidemia groups

From: Synergistic effects of atorvastatin and rosiglitazone on endothelium protection in rats with dyslipidemia

  Sham group (n = 5) Dyslipidemia group (n = 5) P value
Baseline    
TG (mmol/L) 1.03 ± 0.16 1.05 ± 0.11 0.208
TC (mmol/L) 3.08 ± 0.25 3.02 ± 0.19 0.356
LDL-C (mmol/L) 1.89 ± 0.24 1.86 ± 0.18 0.188
HDL-C (mmol/L) 0.77 ± 0.10 0.75 ± 0.09 0.275
FBG (mmol/L) 4.23 ± 0.34 4.42 ± 0.39 0.106
NO (umol/L) 10.17 ± 1.08 10.20 ± 1.15 0.403
MDA (nmol/mL) 0.92 ± 0.04 0.90 ± 0.07 0.335
CRP (mg/L) 1.87 ± 0.15 1.91 ± 0.20 0.281
ADMA (nmol/L) 46.69 ± 4.32 47.18 ± 5.25 0.308
6 weeks later   
TG (mmol/L) 1.10 ± 0.22 1.87 ± 0.34 0.016
TC (mmol/L) 3.24 ± 0.43 4.98 ± 0.77 0.003
LDL-C (mmol/L) 1.97 ± 0.46 3.00 ± 0.52 < 0.001
HDL-C (mmol/L) 0.82 ± 0.13 0.90 ± 0.10 0.078
FBG (mmol/L) 4.48 ± 0.49 4.50 ± 0.62 0.102
NO (umol/L) 10.46 ± 1.14 6.64 ± 1.08 < 0.001
MDA (nmol/L) 0.98 ± 0.06 3.78 ± 0.62 < 0.001
CRP (mg/L) 1.94 ± 0.23 4.22 ± 0.86 < 0.001
ADMA (nmol/L) 48.51 ± 4.74 66.32 ± 8.90 < 0.001